Boston Scientific (NYSE:BSX) announced that it has completed its acquisition of Iris transcatheter annuloplasty ring developer Millipede (Santa Rosa, Calif.). The company announced the acquisition plan in December last year. The deal was worth approximately $325 million with the opportunity for an additional $125 million based on commercial milestone. The company said in December that […]